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A sintese de dois complexos de EDTA lieterobimetalicos, MgCu(EDTA).6H,O e 
ZnCu(EDTA).6H,O, foi descrita. Ambos foram caracterizados por espectroscopia vibracional 
(infravermellio e Raman) e eletrónica (reflectancia). Alguns testes de dissolutilo emHCl 0.1 mol L'1 e 
em suco gastrico artificial foram tambén efetuados. Os resultados indicano o uso potencial desses 
complexos de cobre como suplemento medicinal humano e veterinàrio e ao simultaneo reforjo dos 
níveis de Mg(II) e Zn(II).
The synthesis of two heterobimetallic EDTA complexes. MgCu(EDTA).6H,O and 
ZnCu(EDTA).6H,O, is described. They were characterized by means of vibrational (infrared and 
Raman) and electronic (reflectance) spectroscopy. Several dissolution tests in 0.1N HC1 and simulated 
gastric juice were also performed. The results support the potential usefulness of these complexes 
for copper supplementation in human and veterinary medicine and to the simultaneous reinforcement 
of Mg(II) and Zn(II) levels.
Keywords: EDTA-complexes, IR spectra. Raman spectra, electronic spectra, dissolution assays, 
copper supplementation
Introduction
Supplementation of essential trace or microtrace 
elements is an area of increasing interest in the field of 
human and veterinary pharmacology. In particular, copper 
supplementation is a problem of wide, strong economic 
and clinical impact due to the fact that a series of well- 
known metabolic disorders and diseases found in both 
humans and animals are clearly related to copper 
deficiencies.1
After iron and zinc, copper is the third most abundant 
transition element in the human body -5-6 and it plays an 
important series of biological functions as it is involved in 
electron transport (for example, plastocyanin, azurin); in 
oxidase systems like amine oxidase, ascorbate-oxidase, 
galactose oxidase and lysyl oxidase; in oxygenases like 
tyrosinases, in the transport of oxygen (hemocyanins); in 
the dismutation of the superoxide radical (superoxide 
dismutase) and even in iron metabolism 
(ceruloplasmin).-3-5-6
There are a number of disorders related to deficiencies 
or to elevate copper levels in the organism. Two hereditary 
diseases concerning copper metabolism are particularly 
well-known: Wilson’s disease and Menkes’ syndrome. Both 
of them occur with a probability of about 1 case per 105 
births. Wilson’s disease involves a pathological 
accumulation of copper in the liver and brain, and becomes 
lethal if left untreated.-5-7-8 Different chelating agents have 
been proposed to remove selectively the excess of 
accumulated copper, D-penicillamine being the most 
effective and widely used.-5
In contrast to Wilson’s disease, Menkes’ syndrome is 
caused by a hereditary dysfunction of the intracellular 
copper transport and, thus, insufficient copper storage.1-5 
A characteristic symptom of this disease is the occurrence 
of “kinky” hair, illustrating clearly the involvement of 
copper-containing proteins in the biosynthesis and 
stabilization of structural and connective tissues. This 
disorder must be treated by continuous supplementation 
of the element. If supplementation is interrupted, a rapid 
and eventually lethal degradation occurs in the central 
nervous system.5
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Other genetic defects causing changes in the amino 
acid sequence of the important antioxidant enzyme Cu/ 
Zn superoxide dismutase-5-6 are responsible for the familiar 
form of amyotrophic lateral sclerosis (ALS), a progressive 
and irreversible neurodegenerative disease of the motor 
system.5 It has also been demonstrated that the copper 
status of humans and animals affects strongly the levels of 
neuropeptides.135
In the case of animals, manifestation of copper 
deficiency includes anemia, diarrhea, bone-disorders, 
reproductive failure, achromotrochia (loss of hair pigment) 
and keratinizacion failure in hair, fur and wool.3-4 One of 
the best known environmentally caused disorders of copper 
metabolism in animals, especially in ruminants, is the 
molybdenum/copper antagonism.-5-9 It appears to result 
from a complexation of Cu(I) by MoO S 2 species as 
formed under reducing conditions in the stomach of the 
ruminants. Thiomolybdates are readily soluble in water 
and are excellent chelating agents for metal centers in low 
oxidation states,10 favouring in this way the copper 
excretion, generating a secondary copper deficiency.
Different copper compounds have been used for copper 
supplementation or for the treatment of different disorders 
and diseases. In the case of Menkes’ disease the Cu(II) 
complex of L-histidine seems particularly effective.1-511 The 
treatment with Cu(I) salts in the presence of sebacic acid 
have also considered as very promising1213 and even 
stoichiometric copper(II) sebacate1415 appears as potentially 
useful. Besides, different simple Cu(II) salts and complexes 
have been shown interesting anti-inflammatory, antiulcer, 
anticonvulsant and antitumoral activity.1-216
Different simple or complex compounds have also been 
used in veterinary pharmacology for the supplementation 
of this element. These included copper sulfate solutions, 
the Cu(II) complexes of glycine or methionine and some 
salts of ethylenediaminetetraacetic acid (EDTA), such as 
CuCaEDTA or Na.CuEDTA.4917 20 Another often used 
system is copper oxide, supported in gelatin capsules, or 
in the form of soluble glass boluses containing other 
micronutrients (for example Co and Se).17-20
As part of a research project devoted to the charac­
terization of copper complexes with recognized pharma­
cological activity, in the last years we have investigated in 
detail some general physicochemical properties of Cu(II) 
complexes of simple amino acids21-5 and small peptides.26218 
We also initiated some fieldwork, using a number of the 
investigated amino acid complexes for the supplementation 
of copper to ruminant’s.29
As a continuation of these studies, we have now 
investigated two EDTA complexes, containing simulta­
neously copper(II) and zinc or magnesium.
EDTA (ethylenediaminetetraacetic acid) is one of the 
best known and most widely used chelating agents in both 
analytical chemistry30 and medicine.2-8 It is a potentially 
hexadentate chelating ligand, as each of the nitrogen atoms 
has a free electron pair and the molecule possesses four 
acidic hydrogens (pK = 2.0, pK. = 2.67, pK3 = 6.16, pK4 = 
10.26).8 The (EDTA)4 anion is capable of complexing 
almost every metal cation in the Periodic Table and the six 
coordinating groups are able to occupy four, five or six 
coordination sites around a central metal cation. The 
degree of EDTA-metal complex formation normally 
depends upon the stability of the particular metal-complex 
and the pH-value of the environment.
For the three metal cations involved in the present 
study, the logarithms of the respective stability constants 
(fl) defined as:
¡3= [M(EDTA)2 ]/ [M2+] [(EDTA)4 ]
are respectively 8.69 (for Mg(II)), 16.50 (for Zn(II)) and 
18.80 (for Cu(II)),30 indicating the peculiar stability of the 
Cu(II) complex. This means that in the Cu(II)/Zn(II) and 
Cu(II)/Mg(II) systems, the copper(II) cation may be 
preferentially chelated by EDTA, whereas the other two 
metals probably remain as countercations, out of the 
coordination sphere. In fact, this behaviour has been 
proved by the structural analysis of a series of 
heterobimetallic EDTA complexes of the type M(HO)4 
[M’ (EDTA)] .2H O31 that crystallizes in the same structure 
as Zn,(EDTA).6H,O32 and Co,(EDTA).6H,O,33 space group 
P2jn and Z = 4. Two different coordination sites are present 
in these compounds and both are roughly octahedral. In 
the “hydrated” site, the M cation is coordinated to four 
water molecules and two cis-oxygen atoms belonging to 
two bridging carboxylate groups of side-chelated centers. 
In the “chelated” site, the M’ cation is bonded to four 
oxygens (one from each carboxylate group) and the two 
nitrogens from the hexadentate EDTA ligand. Therefore, 
the lattice can be described as being constituted by zig­
zag strings of alternating “hydrated” and “chelated” 
complex ions linked through carboxylate bridging groups.
Experimental
Syntheses
MgCu[EDTA].6H:O. A mass of 2.9 g (10 mmol) of 
ethylenedi aminetetraacetic acid were dissolved in 200 mL 
of distilled water, mixed with 0.80 g (10 mmol) of Cu(OH)_ 
and heated after dissolution of the hydroxide. To this 
solution 0.87 g (slightly more than 10 mmol) of MgCO3 
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were added in small portions, under vigorous stirring and 
heating. After half an hour, the remnant carbonate is filtered 
off and the solution concentrated over a water bath up to 
the crystallization of the product. The clear-blue crystals 
were separated and dried in air between filter papers.34
ZnCu[EDTA I.6H.O. This compound was prepared in a 
similar way as above, replacing MgCO3 by ZnCO,. After 
separation of the excess of carbonate and concentration of 
the solution to about 50 mL, the clear-blue crystals were 
precipitated by addition of cold methanol.34
Spectroscopic measurements
The infrared spectra were recorded with a Perkin Elmer 
580 B spectrophotometer in the spectral range between 
4000 and 200 cm1, using the KBr pellet technique. Raman 
spectra were measured, on the powdered samples of the 
complexes in a capillary tube, with a Jasco TRS-600/SZ-P 
instrument using the 514.5 nm line of an Ar+ laser for 
excitation.
Electronic (reflectance) spectra were recorded with a 
Shimadzu UV-300 spectrophotometer using MgO as a 
standard.
Pharmacological assays
Dissolution tests were performed following the 
recommendations and procedures of the U. S. 
Pharmacopoeia (XXII. Edition).35 The simulated gastric 




The preparation is very easy and the mixed-metal 
complexes are obtained with high yields and in a very 
pure form, as confirmed by the performed chemical analyses 
[for the Cu/Mg complex: Found: C, 25,00; H, 4.90; N, 
5.85; Cu, 13.25. Calc, for C10H12OgN,CuMg.6H,O: C, 
24.80; H, 4.96; N, 5.79; Cu, 13.13%. For the Cu/Zn 
complex: Found: C, 23.05; H, 4.45; N, 5.40; Cu, 12.20. 
Calc. forCinH,,O„N,CuZn.6H,O: C, 22.86; H.4.57; N, 5.33; 
Cu, 12.10%.].
The described synthetic strategy can also be applied 
for the preparation of other similar species.31-34
Vibrational spectra
The infrared and Raman spectra of the two investigated 
complexes are, as expected, very similar. The IR spectrum 
of the Cu/Mg complex is shown in Figure 1 and the 
corresponding Raman spectrum in Figure 2. The band 
positions measured for both complexes, together with the 
proposed assignment for the most characteristic vibrations 
are presented in Table 1. These assignments are mainly 
based on some general references 36 38 as well as on some 
specific spectroscopic studies of EDTA complexes -31-39’41 
and similar Cu(II) chelates of amino acids.23'25 Some aspects 
of these assignments are briefly commented below.
In the higher frequency region (not shown in the 
Figures) a very broad and strong IR-band, originated in
Figure 1. MgCu[EDTA].6H,O complex: IR spectrum between 2000 and 400 cm1.
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Figure 2. MgCu[EDTA].6H,O complex: Raman spectrum between 2000 and 400 cm1.
Table 1. Vibrational spectra of MgCu(EDTA).6H,O and ZnCu(EDTA).6H,O in the spectral range between 1800 and 400 cm 1
MgCu(EDTA).6H,O ZnCu(EDTA).6H,O Assignment
IR Raman IR Raman
1731sh,1692sh 1702 sh, 1683w
1665 w 1665 sh
1612 sh 1626 sh
1592 vs 1595 w 1605 vs 1595 m r s(COO ) md
1575 sh 1570 m 1575 sh 1565 m v/COO) br
1541m.1524sh
1491 m
1446 s 1449 vs 1435 sh 1435 m ¿(CH,)
1407 s 1420 s 1401 s 1416 s v/COO) br
1378 s 1382 vs 1385 s 1382 vs r/COO) md
1360 sh 1 360vs,l 347vs 1341 m ¿(CH,)
1318 s 1300 vs 1319 s 1305 s ¿(CH,)+ r(C-CO,)
1272 m 1274 m 1268 w 1270 sh ¿(CH2)
1254 s 1248 w
1205 w 1224 m 1227 w 1234 m
1166sh 1140 s 1195 w 1138 s r(CNC)




927 s 927 m 927 m 934 m v(CC)
876 m 875 vs 867 w 876 vs r(CC)
812 m 827 w 812 w 810 w
721 s 720 vw 733 m 761 w P(CH2)
690 vw 692 w 667 w 704 m
646 w 645 w 635 w 615 vw P(H,O) (?)
613 w 621 w 600 sh
593 vw 604 w
562 vw 570 vs 577 w 572 vs see text
538 w 538 vs
498 w
525 vw 538 vs see text
462 w 461 s 467 w 470 s v(Cu-N)
412vw, 392w 438 m 391 w 395 w
Band intensities: vs: very strong: s: strong: m: medium: w: weak: vw: very weak; sh: shoulder.
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the O-H stretchings of the six HO molecules, is observed 
for both complexes. It is centered at about 3425 cm4 in the 
Mg/Cu complex and at 3435 cm4 in the Zn/Cu complex. 
On the lower-frequency side of this broad band some 
features, at about 2960 and 2920 cm1, related to the 
stretching vibrations of the CH -groups were observed.
The HOH bending mode could not be identified with 
certainty, it surely contributes to the observed broadening 
of the central and most intense IR band around 1600 cm4 as 
well as to the corresponding Raman band in the same spectral 
region. One of the vibrational modes of coordinated water 
was also tentatively assigned in Table 1.
As derived from the structural characteristics discussed 
above, two different types of carboxylate groups are present 
in the “chelated” site of these compounds, as two of them 
participated in bridge bonding between the two metal centers 
whereas the other two form only monodentate bonds with 
the Cu(II) centers. Therefore, one expects two groups of 
carboxylate stretching vibrations. In Table 1 they have been 
identified as md (for the monodentate groups) and br (for 
the bridging groups). The v (COO) vibration of the second 
group is not easy to identify, as it only appears as a relatively 
weak shoulder on the lower frequency side of the main band, 
related to this same mode of the monodentated carboxylates. 
On the contrary, in the Raman spectra, both bands can be 
clearly differentiated. The corresponding v (COO ) 
vibrations are more cleanly separated in both spectra.
The mentioned carboxylate stretching vibrations 
satisfactorily fulfill some well-known criteria regarding 
its spectral position and the energy differences between 
the antisymmetric and symmetric vibration.38 This energy 
difference (Av) for the monodentate coordinating groups 
is 214 cm4 in the Cu/Mg complex and 220 cm4 the Cu/Zn 
complex. As expected, these Av-values are clearly higher 
than those of the bridging carboxylate groups (168 cm4 
for Mg/Cu and 174 cm4 for Cu/Zn).
In assigning deformational modes of the CH groups 
we have not differentiated between different kinds of 
possible motions. Only the characteristic rocking (p) mode 
was separately identified. Some of these modes, as well as 
other skeletal modes are probably coupled together and 
can not be considered as “pure” vibrations.
Some relatively strong Raman lines in the spectral range 
below 600 cm4 could not be confidently assigned. They 
are probably motions related to the CuN_O4-skeleton of 
the “chelated” site.
Regarding the metal-to-ligand vibrations, only one of 
the Cu-N stretching modes could be tentatively assigned. It 
lies in the same region in which this vibration is usually 
found in Cu(II) complexes of amino acids,23415 ammonia and 
ethylendiamine.38 The Cu-O motions involving the 
carboxylate oxygen atoms, are expected to lie at around 300 
cm4, whereas those related to the M-O vibrations involving 
the water molecules surely lie between 300 and 400 cm4.38
Electronic spectra
The electronic (reflectance) spectra of both complexes 
are practically identical, presenting a very strong and broad 
band centered at about 750-770 nm( 13.33-12.98 kK). This 
band is characteristic of the 2E -» 2T “d-d” transition of
g 2g
the Cu(II) cation in an octahedral environment.4243 The 
broadness of this band is also usually observed in simple 
octahedral copper (II) complexes, as a consequence of the 
Jahn-Teller effect, expected to be very important in the 
case of a cP electron configuration.4243
Dissolution assays
They were performed in simulated gastric juice and in 
0.1 mol.L 1 HC1 in order to verify the solubility and the 
speed of dissolution of both compounds. To supply the 
lower-limit copper dose to a normal human adult (about 2 
mg/day), 15.2 mg of the Cu/Mg complex and 16.5 mg of 
the Cu/Zn complex must be administered. The assays were 
performed with 20 mg of each of both compounds.
This dose of each compound was introduced into 250 
mL of the simulated gastric juice and slowly stirred. After 
2 minutes a totally clear solution was observed for both 
salts. These assays were duplicated, with the same results. 
This test confirms the dissolution of the compounds and 
the release of magnesium and zinc into the gastric juice. 
Judging by the color of the obtained dissolutions copper 
probably remains in chelated form as EDTA complex.
The same sample quantities as above were introduced 
into 50 mL of 0.1 mol.L4 HC1, maintained at 37 °C and 
stirred at a constant speed of 60 rpm. The dissolution times, 
obtained from two independent experiments for each 
compound, were similar to those obtained above, i.e., less 
than 2 minutes for the dissolution of both compounds. 
This test accepted by the U.S.P. as an assay for dissolution 
of powders allows a maximum dissolution time of 30 
minutes for one dose.35
We have also repeated these assays with higher doses 
(50-60 mg) to simulate basic animal requirements (see 
below). In these cases dissolution times were also very 
low, lying in the order of 3 minutes.
The commented results confirm a rapid release of the 
divalent metal cations and show that both compounds are 
potentially useful for copper supplementation. They could 
be used as a part of solid mixtures of micronutrients, in the 
form of aqueous solutions, or as an injectable solution.
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Table 2. Minimum copper requirements for humans and animals (a), quantities of the two complexes to be administered to cover these minimum 
copper levels (b) and concentration of the simultaneously administered levels of Mg(II) and Zn(II) (c)
a b b c
Cu(II) Mg/Cu-complex Zn/Cu-complex Mgdlj/ZmTI)
humans 2 mg/d 15.2 mg 16.5 mg 0.76 / 2.05 mg
animals 7 mg/kg 53.3 mg 57.8 mg 2.68 / 7.20 mg
The investigated compounds may also be useful to 
supplement small quantities of Mg(II) and Zn(II) with each 
copper administered dose. For adult humans, the 
requirements of these two elements are in the order of about 
300 mg/day (Mg(II))4-44 and 12-15 mg/day (Zn(II)).4 For 
animals the doses range between 10-15 mg/kg (Mg(II))4 44 
and 20-40 mg/kg (Zn(II)).4
In Table 2 the available quantities of each of the two 
metals are shown, related to the supplemented doses of 
copper. As it can be seen, the supplemented doses for both 
metals lie far away from the minimum requirements. 
Notwithstanding, one or other compound may be selected 
to ameliorate, simultaneously with the copper 
supplementation, zinc or magnesium levels, as needed in 
particular cases.
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